Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Johnson & Johnson Beats Earnings Estimates and Forecasts 2025 Growth
Johnson & Johnson’s latest earnings bested Wall Street estimates, as the company braces for one of its top-selling medicines to go off patent in the coming weeks.
What Analysts Think of Johnson & Johnson Stock Ahead of Earnings
Johnson & Johnson is set to report earnings before the bell Wednesday, with analysts expecting revenue and profit growth from the same time last year.
Johnson & Johnson Q4 Profit Decreases, But Beats Estimates
Johnson & Johnson (JNJ) announced a profit for fourth quarter that decreased from last year but beat the Street estimates. The
J&J’s earnings beat estimates but guidance is mixed
Johnson & Johnson’s stock rose 1.9% early Wednesday, after the medical tech and drug company posted better-than-expected earnings for the fourth quarter, offsetting mixed guidance. The company had per-share earnings of $1.
Earnings call transcript: Johnson & Johnson Q3 2024 beats EPS forecast
Johnson & Johnson (NYSE:JNJ) reported its third-quarter 2024 earnings, surpassing analysts' expectations with an adjusted earnings per share (EPS) of $2.04, slightly above the forecasted $2.02. The company's revenue also exceeded projections,
Johnson & Johnson (JNJ) Q4 Earnings and Revenues Top Estimates
Johnson & Johnson (JNJ) came out with quarterly earnings of $2.04 per share, beating the Zacks Consensus Estimate of $2 per share. This compares to earnings of $2.29 per share a year ago. These figures are adjusted for non-recurring items.
Johnson & Johnson Q4 2024 Earnings Preview: Double-digit decline in profit expected
Johnson & Johnson (NYSE:JNJ) is scheduled to announce Q4 earnings results on Wednesday, January 22nd, before market open. Analysts expect a profit per share of $2.02, which is a decline of 11.8% from the prior year period.
18h
on MSN
FDA approves Johnson & Johnson’s nasal spray for depression as stand-alone treatment
Spravato is now the first-ever stand-alone therapy for treatment-resistant depression, and is on its way to becoming a ...
1d
Ben Johnson to Chicago Bears is a gut punch because he knows the Detroit Lions' recipe
Chicago has hired Detroit Lions OC Ben Johnson to be their next head coach. The toughest division in the NFL could get even ...
TipRanks on MSN
3d
Johnson & Johnson’s New Acquisition Could Result in Tremendous Rewards
Staying ahead of the competition is critical in every sector, particularly in the dynamic healthcare space, where a single ...
1d
Johnson & Johnson (JNJ) Receives a Hold from Morgan Stanley
In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Johnson & Johnson (JNJ – Research Report), with a ...
10h
on MSN
Jim Cramer on Johnson & Johnson (JNJ): ‘Make Good Money Just By Reinvesting Their Juicy Dividends’
We recently published an article titled Jim Cramer Discussed 9 Stocks for This Week’s Game Plan. In this article, we are ...
17h
on MSN
Dakota Johnson and Chris Martin Hold Hands While on Walk Together in Mumbai
Dakota Johnson and Chris Martin were photographed holding hands as they went for a walk in Mumbai on Tuesday, Jan. 21. Martin ...
14h
Credit Bears brass for winning Ben Johnson's recruiting battle
It was easy to roll your eyes two weeks ago Wednesday when Warren painted the Bears’ head coaching job as the best available ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Trump
New York
NFL
Chicago Bears
California
Feedback